Genomix Pharmaceuticals Private Limited
Founded in 2011 and headquartered in Jharkhand, India.
2011 | Ranchi, Jharkhand (India) | Active
Genomix Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 1.80 M
- Company Age 14 Year, 27 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
- Satisfied Charges ₹ 2.50 M
About Genomix Pharmaceuticals
Genomix Pharmaceuticals Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 February 2011 and has a history of 14 years. Its registered office is in Ranchi, Jharkhand, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.80 M.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Mrinal Gupta, Mira Gupta, and Rupa Gupta serve as directors at the Company.
Company Details
- Location
Ranchi, Jharkhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909JH2011PTC014694
- Company No.
014694
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Trading
Genomix Pharmaceuticals Private Limited
Explore comprehensive data for Genomix Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Genomix Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mrinal Gupta  | Director | 17-Feb-2011 | Current |
| Mira Gupta | Director | 25-Jun-2013 | Current |
| Rupa Gupta | Director | 17-Jun-2020 | Current |
Financial Performance of Genomix Pharmaceuticals.
Genomix Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Genomix Pharmaceuticals?
In 2017, Genomix Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹5.00 M
Satisfied Charges
₹2.50 M
Charges Breakdown by Lending Institutions
- Others : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Sep 2020 | Others | ₹5.00 M | Open |
| 12 May 2016 | Others | ₹2.50 M | Satisfied |
How Many Employees Work at Genomix Pharmaceuticals?
Unlock and access historical data on people associated with Genomix Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genomix Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genomix Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Genomix Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Genomix Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Genomix Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jharkhand.
- Charges
A charge with Others amounted to Rs. 5.00 M with Charge ID 100375377 was registered on 11 Sep 2020.
- Director Appointment
Rupa Kumari Gupta was appointed as a Director was appointed as a Director on 17 Jun 2020 & has been associated with this company since 4 years 8 months .
- Charges
A charge registered on 12 May 2016 via Charge ID 100029228 with Others was fully satisfied on 29 Aug 2019.
- Charges
A charge with Others amounted to Rs. 2.50 M with Charge ID 100029228 was registered on 12 May 2016.
Frequently asked questions
What is the Incorporation or founding date of Genomix Pharmaceuticals Private Limited?
Genomix Pharmaceuticals Private Limited was incorporated on 17 Feb 2011.
What is authorized share capital and paid-up capital of Genomix Pharmaceuticals Private Limited?
The authorized share capital of Genomix Pharmaceuticals Private Limited is ₹ 5.00 M and paid-up capital is ₹ 1.80 M.
Who are the current board members & directors of Genomix Pharmaceuticals Private Limited?
Currently 3 directors are associated with Genomix Pharmaceuticals Private Limited.
- Mrinal Kumar Gupta
- Mira Gupta
- Rupa Kumari Gupta
What is the registered address of Genomix Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Genomix Pharmaceuticals Private Limited is Dinbandhu Lane Upper Bazar India, Ranchi, Jharkhand, 834001.
What is the corporate identification number (CIN) and company number of Genomix Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Genomix Pharmaceuticals Private Limited is U51909JH2011PTC014694 and the company number is 014694 as per Ministry of Corporate Affairs (MCA).
What are the total open charges for Genomix Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2017, The total open charges for Genomix Pharmaceuticals Private Limited amount to ₹ 5.00 M.
When was the last Balance Sheet of Genomix Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Genomix Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
PS
Prabhat SahuDirector